Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
2012 1
2013 1
2016 2
2017 1
2018 2
2020 2
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Borderline Ovarian Serous Cystadenofibroma"
Page 1
MRI of Borderline Epithelial Ovarian Tumors: Pathologic Correlation and Diagnostic Challenges.
Tsuboyama T, Sato K, Ota T, Fukui H, Onishi H, Nakamoto A, Tatsumi M, Tomiyama N. Tsuboyama T, et al. Radiographics. 2022 Nov-Dec;42(7):2095-2111. doi: 10.1148/rg.220068. Epub 2022 Sep 9. Radiographics. 2022. PMID: 36083804
Borderline epithelial ovarian tumors are a distinct pathologic entity characterized by increased epithelial proliferation and nuclear atypia, but without frank stromal invasion. Borderline tumor (BT) is now considered to represent an intermediate phase in the …
Borderline epithelial ovarian tumors are a distinct pathologic entity characterized by increased epithelial proliferation and …
Is MRI a useful tool to distinguish between serous and mucinous borderline ovarian tumours?
Bazot M, Haouy D, Daraï E, Cortez A, Dechoux-Vodovar S, Thomassin-Naggara I. Bazot M, et al. Clin Radiol. 2013 Jan;68(1):e1-8. doi: 10.1016/j.crad.2012.08.021. Epub 2012 Oct 6. Clin Radiol. 2013. PMID: 23044365
AIM: To analyse the morphological magnetic resonance imaging (MRI) features of borderline ovarian tumours (BOT) and to evaluate whether MRI can be used to distinguish serous from mucinous subtypes. ...Logistic regression analysis was used to assess the pre …
AIM: To analyse the morphological magnetic resonance imaging (MRI) features of borderline ovarian tumours (BOT) and to evaluat …
TFF3 Expression as Stratification Marker in Borderline Epithelial Tumors of the Ovary.
El-Balat A, Schmeil I, Karn T, Becker S, Sänger N, Holtrich U, Arsenic R. El-Balat A, et al. Pathol Oncol Res. 2018 Apr;24(2):277-282. doi: 10.1007/s12253-017-0240-4. Epub 2017 May 3. Pathol Oncol Res. 2018. PMID: 28470574 Free article.
Borderline tumors (BOT) of the ovary account for 10% to 20% of ovarian neoplasms. ...Trefoil factor-3 (TFF3) is an estrogen-regulated gene associated with prognosis in different types of cancer. It has also been included in a recent marker panel predicting …
Borderline tumors (BOT) of the ovary account for 10% to 20% of ovarian neoplasms. ...Trefoil factor-3 (TFF3) is an estrogen-re …
Clinical Predictors of Recurrence and Prognostic Value of Lymph Node Involvement in the Serous Borderline Ovarian Tumor.
Qian XQ, Hua XP, Wu JH, Shen YM, Cheng XD, Wan XY. Qian XQ, et al. Int J Gynecol Cancer. 2018 Feb;28(2):279-284. doi: 10.1097/IGC.0000000000001154. Int J Gynecol Cancer. 2018. PMID: 29194193
AIM: This study was aimed to evaluate the risk factors of recurrence and the value of nodal involvement in patients with serous borderline ovarian tumors (SBOT). METHODS: Two hundred twenty-five patients who underwent surgery and were diagnosed with SBOT were …
AIM: This study was aimed to evaluate the risk factors of recurrence and the value of nodal involvement in patients with serous bo …
On the histogenesis and morphology of ovarian carcinomas.
Dallenbach-Hellweg G. Dallenbach-Hellweg G. J Cancer Res Clin Oncol. 1984;107(2):71-80. doi: 10.1007/BF00399375. J Cancer Res Clin Oncol. 1984. PMID: 6715398
Serous papillary carcinomas form the largest group containing about 50% of all ovarian carcinomas. ...Statistically significant data for predicting the prognosis for rare carcinomas are not available....
Serous papillary carcinomas form the largest group containing about 50% of all ovarian carcinomas. ...Statistically significan …
Classification of Extraovarian Implants in Patients With Ovarian Serous Borderline Tumors (Tumors of Low Malignant Potential) Based on Clinical Outcome.
McKenney JK, Gilks CB, Kalloger S, Longacre TA. McKenney JK, et al. Am J Surg Pathol. 2016 Sep;40(9):1155-64. doi: 10.1097/PAS.0000000000000692. Am J Surg Pathol. 2016. PMID: 27428735
The classification of extraovarian disease into invasive and noninvasive implants predicts patient outcome in patients with high-stage ovarian serous borderline tumors (tumors of low malignant potential). ...Because the presence of invasion in an extra …
The classification of extraovarian disease into invasive and noninvasive implants predicts patient outcome in patients with high-stag …
Endocrine cell micronests in an ovarian mucinous borderline tumor: a potential diagnostic pitfall for microinvasion.
Collins K, Segura S, Hwang M. Collins K, et al. Diagn Pathol. 2022 Apr 14;17(1):37. doi: 10.1186/s13000-022-01217-4. Diagn Pathol. 2022. PMID: 35422044 Free PMC article.
The occurrence of endocrine cell micronests in ovarian tumors is rarely reported. To our knowledge, there are only three prior cases reported to date: one occurring in an ovarian mucinous cystadenoma, one in an ovarian mucinous cystadenofibroma, and an …
The occurrence of endocrine cell micronests in ovarian tumors is rarely reported. To our knowledge, there are only three prior cases …
OVARIAN CANCER TREATMENT OPTIMIZATION: THE COMPLEX ANALYSIS OF THE RESULTS OF CYTOREDUCTIVE SURGERY, MICROSCOPIC MALIGNANCY AND T-LYMPHOCYTIC INFILTRATION OF THE TUMOR.
Khatchapuridze K, Tananashvili D, Todua K, Kekelidze N, Tsitsishvili Z, Mchedlishvili M, Kordzaia D. Khatchapuridze K, et al. Georgian Med News. 2020 Oct;(307):23-30. Georgian Med News. 2020. PMID: 33270572
According to the obtained data, the carcinogenesis of high-grade and low-grade serous ovarian carcinoma is different: low-grade forms are always preceded by serous cystadenoma and/or serous cystadenofibroma, which progresses to borderline …
According to the obtained data, the carcinogenesis of high-grade and low-grade serous ovarian carcinoma is different: low-grad …
Psammoma bodies in Papanicolaou tests and associated factors to predict an underlying malignancy: a clinicopathological analysis of 10 cases.
Ersoy E, Kashikar RM. Ersoy E, et al. J Am Soc Cytopathol. 2020 Jul-Aug;9(4):266-271. doi: 10.1016/j.jasc.2020.04.002. Epub 2020 Apr 11. J Am Soc Cytopathol. 2020. PMID: 32376242
Six patients with age ranging from 19 to 58 years (mean age, 37.6 years) had benign outcome (eg, endometritis, ovarian serous cystadenofibroma). Four patients with age ranging from 31 to 54 years (mean age, 41.7 years) had borderline/malignant outcome …
Six patients with age ranging from 19 to 58 years (mean age, 37.6 years) had benign outcome (eg, endometritis, ovarian serous …
Low-grade Serous Carcinoma of the Ovary: Clinicopathologic Analysis of 52 Invasive Cases and Identification of a Possible Noninvasive Intermediate Lesion.
Ahn G, Folkins AK, McKenney JK, Longacre TA. Ahn G, et al. Am J Surg Pathol. 2016 Sep;40(9):1165-76. doi: 10.1097/PAS.0000000000000693. Am J Surg Pathol. 2016. PMID: 27487741
Low-grade serous carcinoma (LGSC) is an uncommon but distinct histologic subtype of ovarian carcinoma. ...To refine the criteria for invasion patterns of LGSC and determine additional clinically pertinent morphologic features of LGSC predisposing to a more aggressiv …
Low-grade serous carcinoma (LGSC) is an uncommon but distinct histologic subtype of ovarian carcinoma. ...To refine the criter …